Autolus Therapeutics

+$0.12 (+1.98%) Today
+$0.17 (+2.76%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell AUTL and other stocks, options, and ETFs commission-free!

About AUTL

Autolus Therapeutics plc American Depositary Share, also called Autolus Therapeutics, is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells.

CEO
Christian Martin Itin
Employees
384
Headquarters
London, Greater London
Founded
2018

AUTL Key Statistics

Market Cap
358.85M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.40M
High Today
$6.30
Low Today
$6.01
Open Price
$6.04
Volume
1.22M
52 Week High
$17.19
52 Week Low
$4.60

AUTL Earnings

-$0.93
-$0.62
-$0.31
-$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.60 per share
Actual
-$0.53 per share
Replay Earnings Call

You May Also Like

MPLX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure